LHC Group, Inc. (LHCG) Stock Price Hits 52-Week High Today

June 17, 2018 - By Marguerite Chambers

LHC Group, Inc. (NASDAQ:LHCG) Logo

Investors sentiment decreased to 0.87 in 2018 Q1. Its down 0.28, from 1.15 in 2017Q4. It dived, as 28 investors sold LHC Group, Inc. shares while 62 reduced holdings. 30 funds opened positions while 48 raised stakes. 16.80 million shares or 7.21% more from 15.67 million shares in 2017Q4 were reported.
Bessemer Group Inc reported 13,400 shares. Morgan Stanley has 64,332 shares. Waddell Reed reported 503,200 shares stake. Glenmede Trust Com Na invested 0% in LHC Group, Inc. (NASDAQ:LHCG). Coliseum Management Limited Com invested 6.87% in LHC Group, Inc. (NASDAQ:LHCG). Swiss Bank reported 28,635 shares stake. New York-based Ltd Liability Co has invested 0.18% in LHC Group, Inc. (NASDAQ:LHCG). State Of Alaska Department Of Revenue reported 0.01% of its portfolio in LHC Group, Inc. (NASDAQ:LHCG). Globeflex Limited Partnership reported 16,026 shares. Robeco Institutional Asset Mngmt Bv owns 0.01% invested in LHC Group, Inc. (NASDAQ:LHCG) for 48,714 shares. Oberweis Asset Management stated it has 2.26% of its portfolio in LHC Group, Inc. (NASDAQ:LHCG). New York-based Goldman Sachs Gru has invested 0% in LHC Group, Inc. (NASDAQ:LHCG). California State Teachers Retirement has invested 0% of its portfolio in LHC Group, Inc. (NASDAQ:LHCG). Kennedy Capital Mgmt accumulated 0.07% or 61,056 shares. Mason Street Advisors Limited accumulated 7,652 shares.

Since March 13, 2018, it had 0 buys, and 4 selling transactions for $2.18 million activity. The insider Reibel Jeff sold 3,000 shares worth $217,050. 14,216 shares were sold by Stelly Donald Dwayne, worth $909,824.

The stock of LHC Group, Inc. (NASDAQ:LHCG) hit a new 52-week high and has $91.84 target or 9.00 % above today’s $84.26 share price. The 8 months bullish chart indicates low risk for the $2.77B company. The 1-year high was reported on Jun, 17 by Barchart.com. If the $91.84 price target is reached, the company will be worth $249.03 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 1.03% or $0.86 during the last trading session, reaching $84.26. About 286,094 shares traded. LHC Group, Inc. (NASDAQ:LHCG) has risen 24.77% since June 17, 2017 and is uptrending. It has outperformed by 12.20% the S&P500.

Analysts await LHC Group, Inc. (NASDAQ:LHCG) to report earnings on August, 1. They expect $0.81 EPS, up 28.57 % or $0.18 from last year’s $0.63 per share. LHCG’s profit will be $26.60 million for 26.01 P/E if the $0.81 EPS becomes a reality. After $0.63 actual EPS reported by LHC Group, Inc. for the previous quarter, Wall Street now forecasts 28.57 % EPS growth.

LHC Group, Inc. (NASDAQ:LHCG) Ratings Coverage

Among 4 analysts covering LHC Group (NASDAQ:LHCG), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. LHC Group has $8500 highest and $74.0 lowest target. $79.67’s average target is -5.45% below currents $84.26 stock price. LHC Group had 4 analyst reports since January 23, 2018 according to SRatingsIntel. William Blair maintained the shares of LHCG in report on Tuesday, January 23 with “Buy” rating. The rating was maintained by SunTrust with “Buy” on Tuesday, April 17. Stephens maintained the stock with “Buy” rating in Thursday, March 1 report. The stock of LHC Group, Inc. (NASDAQ:LHCG) earned “Buy” rating by Craig Hallum on Wednesday, April 4.

Another recent and important LHC Group, Inc. (NASDAQ:LHCG) news was published by Nasdaq.com which published an article titled: “Detailed Research: Economic Perspectives on Dorchester Minerals, MEDIFAST INC, Sabra Healthcare REIT …” on May 30, 2018.

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company has market cap of $2.77 billion. The firm operates through four divisions: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. It has a 30.2 P/E ratio. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

LHC Group, Inc. (NASDAQ:LHCG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.